The emerging use of novel psychoactive substances in the UK presents a significant risk to public well-being. Often marketed online, these chemicals frequently lack extensive testing and their consequences are largely understood. Obtaining them carries a substantial chance of encountering unpredictable negative reactions, adulteration, and potentia